Screener
Kymera Therapeutics KYMR Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration revenue | $65,000 | $11,476 | $99,365 | $33,576 |
| Operating expenses: | ||||
| Research and development | $119,481 | $78,388 | $217,644 | $158,643 |
| General and administrative | 21,126 | 17,645 | 41,484 | 33,916 |
| Total operating expenses | 140,607 | 96,033 | 259,128 | 192,559 |
| Loss from operations | (75,607) | (84,557) | (159,763) | (158,983) |
| Other income (expense): | ||||
| Interest and other income | 14,477 | 8,051 | 29,459 | 16,968 |
Item 1. Financial Statements.
FAQ
- What is Kymera Therapeutics's total revenue?
- Kymera Therapeutics (KYMR) reported total revenue of $65M in Q2 2026.
- How has Kymera Therapeutics's total revenue changed year-over-year?
- Kymera Therapeutics's total revenue increased by 466.4% year-over-year, from $11.48M to $65M.
- What is the long-term trend for Kymera Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Kymera Therapeutics's total revenue has grown at a -14.3% compound annual growth rate (CAGR), from $72.83M to $39.21M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Kymera Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude